We are live on ! Find out more
EXEL icon

Exelixis

344 hedge funds and large institutions have $4.46B invested in Exelixis in 2018 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 127 increasing their positions, 100 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more call options, than puts

Call options by funds: $100M | Put options by funds: $58M

67% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 42

27% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 100

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

9% more funds holding

Funds holding: 316344 (+28)

7% more capital invested

Capital invested by funds: $4.16B → $4.46B (+$299M)

2.1% less ownership

Funds ownership: 78.79%76.69% (-2.1%)

Holders
344
Holders Change
+28
Holders Change %
+8.86%
% of All Funds
7.66%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.13%
New
70
Increased
127
Reduced
100
Closed
42
Calls
$100M
Puts
$58M
Net Calls
+$42.3M
Net Calls Change
-$2.5M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$602M +$8.75M +490,747 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$538M +$14.4M +808,630 +3%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$419M -$59.3M -3,328,047 -14%
MG
4
Meditor Group
Bermuda
$314M
AQR Capital Management
5
AQR Capital Management
Connecticut
$213M +$140M +7,871,625 +266%
State Street
6
State Street
Massachusetts
$182M -$36.4M -2,041,344 -18%
JP Morgan Chase
7
JP Morgan Chase
New York
$178M +$55.2M +3,097,622 +52%
CCM
8
Consonance Capital Management
New York
$131M +$49.3M +2,766,063 +71%
Renaissance Technologies
9
Renaissance Technologies
New York
$116M +$32.5M +1,821,017 +44%
Goldman Sachs
10
Goldman Sachs
New York
$110M -$16.4M -919,558 -14%
First Trust Advisors
11
First Trust Advisors
Illinois
$109M +$16.2M +907,412 +20%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$73.6M +$11.5M +643,023 +21%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$59.6M -$7.16M -401,575 -12%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$59.2M +$3.75M +210,181 +8%
BB
15
BB Biotech
Switzerland
$55.8M +$891K +50,000 +2%
O
16
OrbiMed
New York
$55.1M
Norges Bank
17
Norges Bank
Norway
$54.6M +$4.3M +241,388 +10%
Northern Trust
18
Northern Trust
Illinois
$45.3M +$743K +41,677 +2%
Fiera Capital (Canada)
19
Fiera Capital (Canada)
Quebec, Canada
$39.4M +$35.7M +2,001,493 New
FCM
20
Farallon Capital Management
California
$39.3M +$16.4M +920,000 +85%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$39M +$11.2M +629,369 +46%
American Century Companies
22
American Century Companies
Missouri
$34.8M -$12.7M -713,234 -29%
Prudential Financial
23
Prudential Financial
New Jersey
$31.4M +$23.3M +1,308,617 +452%
Millennium Management
24
Millennium Management
New York
$29M -$13M -728,515 -33%
Deutsche Bank
25
Deutsche Bank
Germany
$28M -$17.1M -958,010 -40%

EXEL Hedge Fund Activity: Q4 2018 in Review

344 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q4 2018, worth a combined $4.46B — up 7.2% from $4.16B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new EXEL positions and 42 closed out — a net gain of 28 holders — while 127 added to existing stakes and 100 trimmed.

The largest buyer was AQR Capital Management, adding an estimated $140M. The largest seller was Matrix Capital Management Company, exiting entirely with an estimated $177M sold.

  • 344 institutional investors held Exelixis (EXEL) as of Q4 2018, up from 316 in Q3 2018.
  • Funds reported $4.46B of Exelixis stock for Q4 2018, up 7.2% quarter-over-quarter.
  • 70 funds opened new Exelixis positions in Q4 2018 and 42 closed out, a net change of +28 holders.
  • The largest Exelixis buyer in Q4 2018 was AQR Capital Management, an estimated $140M added.
  • The largest Exelixis seller in Q4 2018 was Matrix Capital Management Company, an estimated $177M sold.

Based on aggregated 13F filings for Q4 2018.